Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butylphthalide and serum NfL registry study in ischemic stroke
ChiCTR2000029902Phase 4Not yet recruiting
- Sponsor
- Deyang People's Hospital
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of butylphthalide in ischemic stroke (2 arms), sponsored by Deyang People's Hospital. Primary endpoint: Incidence of early neurological deterioration. Planned start Mar 2020; status: not yet recruiting.
02
Drugs
butylphthalide
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2000029902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000029902.